Free Corporate Rating

Free Corporate Rating

Discover how companies are aligning with the Paris Agreement’s goal of limiting global warming to 2°C. This tool provides you with up-to-date climate ratings, reflecting a company’s progress and commitment to sustainable practices. Whether you're an investor, policymaker, or eco-conscious consumer, our platform simplifies your search for transparent, data-driven insights on corporate climate performance.
Start exploring now and make informed decisions for a sustainable future !

REGENERON PHARMACEUTICALS, INC.

Health Care

ISIN

US75886F1075

LEI

549300RCBFWIRX3HYQ56

Description

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. It focuses on developing treatments for eye diseases, inflammatory and immune disorders, cancer, and other conditions.
Priority Engaging
● SB2A temperature range: ≥ 4°C ● Description: Priority Engaging companies face a critical need for environmental improvement. With SB2A indicating a substantial temperature misalignment (≥ 4°C), these companies are recognized as having a very high environmental impact. Priority Engaging companies are urged to prioritize and accelerate their sustainability initiatives to address their significant climate-related challenges.

Rating peers in sector of Health Care (based on 269 companies)

1%
Priority
Enabling
1%
Enabling
1%
Priority
Transitioning
3%
Transitioning
10%
Engaging
REGENERON PHARMACEUTICALS, INC.
84%
Priority
Engaging

Get in touch!

Want to know more? Fill out the form or reach us directly via email at contact@icebergdatalab.com.

France
ICEBERG DATA LAB
39 Avenue Victor Hugo
75116 Paris
📞 +33 1 89 71 64 00
United Kingdom
ICEBERG DATA LAB
1 Fore Street Avenue
EC2Y 9DT London
Germany
ICEBERG DATA LAB
Platz der Einheit 2
60327 Frankfurt am Main, Frankfurt
United States
ICEBERG DATA LAB
100 Cummings Center
Beverly, MA 01915
📞 +1 (351) 235-2879